ERBB2 and breast neoplasm: Further analysis of miR-342 and miR-520g in 95 breast tumors resulted in the identification that miR-342 expression is lowest in TNBC in comparison to ER and HER2/neu positive luminal breast tumors while miR-520g is up regulated in ER and PR negative tumors (183).